Moderna ties the knot with Thermo Fisher on a 15-year manufacturing alliance, gluing a global network
After marshaling the manufacturing forces at Thermo Fisher to meet huge demand for its Covid-19 vaccine, the top execs at Moderna have now hammered out a deal that should keep its mRNA products flowing for the next 15 years.
The manufacturing conglomerate has already been providing Moderna with aseptic fill-finish services and packaging of its Covid-19 vaccine. In this expanded alliance, Thermo Fisher is carving out dedicated fill-finish services along with “inspection, labeling and final packaging services.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.